Atea Pharmaceuticals Stock Discussion

$Atea Pharmaceuticals(AVIR.US)$
NEWS
Atea Pharmaceuticals Presents New Data Showcasing Potential Best-in-Class Combination Profile of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus at EASL Congress 2024

$Atea Pharmaceuticals(AVIR.US)$
NEWS
Atea Announces Presentation of Data Highlighting Favorable Safety Profile of Bemnifosbuvir at ESCMID Global 2024
Atea Pharmaceuticals, Inc. announced the Phase 1 data presentation at ESCMID Global 2024, highlighting the favorable safety profile of bemnifosbuvir, an oral nucleotide polymerase inhibitor. The results show no cardiotoxicity in healthy participants, supporting the drug's safety profile. Atea aims to address the unmet need for COVID-19 and HCV trea...

$Atea Pharmaceuticals(AVIR.US)$  😎

$Pfizer(PFE.US)$  Phase 3
$BioCardia(BCDA.US)$  Phase 3
$Atea Pharmaceuticals(AVIR.US)$  Phase 3
$Crinetics(CRNX.US)$  Phase 3
$Axsome Therapeutics(AXSM.US)$  Phase 3
$ROCHE HOLDING AG(RHHBY.US)$  Phase 3
$ACADIA Pharmaceuticals(ACAD.US)$  Phase 3
$Sellas Life Sciences(SLS.US)$  Phase 3
$Aquestive Therapeutics(AQST.US)$  Phase 3
$Jaguar Health(JAGX.US)$  Phase 3
$Novocure(NVCR.US)$  Phase 3
$Johnson & Johnson(JNJ.US)$  Phase 3

🎯 Ph 3 readouts in Q1 2024...
$Pfizer(PFE.US)$  Phase 3
$Palatin Technologies(PTN.US)$  Phase 3
$Annovis Bio(ANVS.US)$  Phase 3
$BioCardia(BCDA.US)$  Phase 3
$Atea Pharmaceuticals(AVIR.US)$  Phase 3
$Ironwood Pharmaceuticals(IRWD.US)$  Phase 3
$Alnylam Pharmaceuticals(ALNY.US)$  Phase 3
$Axsome Therapeutics(AXSM.US)$  Phase 3
$ $Novocure(NVCR.US)$  Phase 3
$ROCHE HOLDING AG(RHHBY.US)$  Phase 3
$FibroGen(FGEN.US)$  Phase 3
$ACADIA Pharmaceuticals(ACAD.US)$  Phase 3
$Sellas Life Sciences(SLS.US)$...

$Atea Pharmaceuticals(AVIR.US)$  good looking chart 😎😎. Drop us some news !

$Pfizer(PFE.US)$  Phase 3
$Regenxbio(RGNX.US)$  Phase 3
$Annovis Bio(ANVS.US)$  Phase 3
$Atea Pharmaceuticals(AVIR.US)$  Phase 3
$Ironwood Pharmaceuticals(IRWD.US)$  Phase 3
$Alnylam Pharmaceuticals(ALNY.US)$  Phase 3
$Vertex Pharmaceuticals(VRTX.US)$  Phase 3
$KalVista Pharmaceuticals(KALV.US)$  Phase 3
$Axsome Therapeutics(AXSM.US)$  Phase 3
$Novocure(NVCR.US)$  Phase 3
$ROCHE HOLDING AG(RHHBY.US)$  Phase 3
$FibroGen(FGEN.US)$  Phase 3
$Applied Therapeutics(APLT.US)$  Phase 3
$ACADIA Pharmaceuticals(ACAD.US)$  Phase 3...

$Cellectar BioSciences(CLRB.US)$ Phase 2
$Regenxbio(RGNX.US)$ Phase 2
$Leap Therapeutics(LPTX.US)$ Phase 2
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals(EYPT.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US)$ Phase 2
$Disc Medicine(IRON.US)$ Phase 2
$Atea Pharmaceuticals(AVIR.US)$ Phase 2
$Allakos(ALLK.US)$ Phase 2...

$Atea Pharmaceuticals(AVIR.US)$ this means it will delist at take over price?